Upload
Featured Recent Articles Topics Login Upload

Search Results for 'product clinical'

product clinical published presentations and documents on DocSlides.

JMP Clinical 17 Sam Gardner
JMP Clinical 17 Sam Gardner
by evelyn
Senior Product Manager for Health and Life Science...
Quality Issues for Clinical Trial Materials
Quality Issues for Clinical Trial Materials
by min-jolicoeur
: . The Chemistry, Manufacturing and Controls (CM...
Terminologies in Clinical Research
Terminologies in Clinical Research
by trish-goza
Adverse Drug Reactions (ADR). All . noxious . and...
Product Introduction for Advocates
Product Introduction for Advocates
by king142
Basic Elements of Product Introduction for HIV Pre...
Non-clinical d evelopment
Non-clinical d evelopment
by jade
Once a lead molecule (candidate compound) is ident...
Recording and Reporting Clinical Trial Results
Recording and Reporting Clinical Trial Results
by emery
T. he . trial sponsor . compiles . a detailed clin...
Fifteen Cell TherapiesStem Cell Therapies in Phase III Clinical Trial
Fifteen Cell TherapiesStem Cell Therapies in Phase III Clinical Trial
by genevieve
By Brandy Sargent Editor, Cell Culture Dish www.ce...
The Clinical Trial Protocol: Writing Considerations
The Clinical Trial Protocol: Writing Considerations
by kittie-lecroy
AMWA Northern California Chapter . 04 Oct 2014. 1...
Maternal immunization: Regulatory
Maternal immunization: Regulatory
by kyler
and . Ethical . considerations. in the EU. Pieter ...
FDA’s Clinical Investigator Course
FDA’s Clinical Investigator Course
by beatrice
Preparing an IND Application: CBER Breakout Sessi...
1 Immunogenicity The key safety issue for biosimilars
1 Immunogenicity The key safety issue for biosimilars
by gelbero
Prof. Ibrahim A. . Alsarra. Professor . of . Phar...
E2A Document History
E2A Document History
by danya
First Codification History Date New Codificatio...
ENGLISH ONLY FINAL EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Ge
ENGLISH ONLY FINAL EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Ge
by edolie
GUIDELINES ON EVALUATION OF SIMILAR BIOTHERAPEUTIC...
These statements
These statements
by walsh
* have not been evaluated by the FDA. Th i s produ...
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
by calandra-battersby
OMIC Group Biosimilars 2014. Hyderabad India. 27-...
Comparison of US/EU Biosimilar
Comparison of US/EU Biosimilar
by aaron
Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...
Comparison of US/EU Biosimilar
Comparison of US/EU Biosimilar
by myesha-ticknor
Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...
Biosimilar Biological Products
Biosimilar Biological Products
by luanne-stotts
2016 . Clinical Investigator . Training Course. S...
Biosimilars Guideline – a Summary of the Industry Comments
Biosimilars Guideline – a Summary of the Industry Comments
by marina-yarberry
M Bredenhann | Nycomed | 19.11.10. BIOSIMILAR...
Comparison of US/EU Biosimilar
Comparison of US/EU Biosimilar
by danika-pritchard
Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...
Faculty Leonard H. Calabrese, DO
Faculty Leonard H. Calabrese, DO
by trish-goza
Professor of Medicine. Cleveland Clinic Lerner Co...
Biological Products: concepts, naming,
Biological Products: concepts, naming,
by faustina-dinatale
interchangeability,extrapolation. and safety. Dr...
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
by stefany-barnette
OMIC Group Biosimilars 2014. Hyderabad India. 27-...
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
by calandra-battersby
OMICS Group Biosimilars 2015 Birmingham, UK. 10-1...
Ethical Issues Related to Compassionate Use
Ethical Issues Related to Compassionate Use
by min-jolicoeur
RDLA, . February 26, 2014. Michael J. Werner. Ove...
Product Commercialisation
Product Commercialisation
by stella
Process at . Thermo. Fisher Scientific. Paul Blac...
PRODUCT CATALOGUE
PRODUCT CATALOGUE
by freya
SEROs range of Branded Control SeraSERO the indepe...
Paving the Road Toward Setting Clinically Relevant Drug Product
Paving the Road Toward Setting Clinically Relevant Drug Product
by alexa-scheidler
Specifications. : . . Biopharmaceutics . Perspec...
Managing Data and Projects Across the Globe
Managing Data and Projects Across the Globe
by louie378
University of Massachusetts Software Engineering....
Official address
Official address
by gelbero
Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ●...
European Medicines Agency 7 Westferry Circus Canary Wharf London E1
European Medicines Agency 7 Westferry Circus Canary Wharf London E1
by jalin
(CHMP) GUIDELINE ON FOLLOW-UP OF PATIENTS ADMINIS...
What DOES This “REALLY” LOOK Like?
What DOES This “REALLY” LOOK Like?
by SillyGoose
Lean Launch Pad – fast forward 6 weeks. 1. But,...
National Health Science Foundation
National Health Science Foundation
by maddoxjustin
Accredited Independent Mark of Efficacy (AIME. TM....
Dosage Form Design Chapter 1
Dosage Form Design Chapter 1
by scarlett
Dr. . . Athmar. . Dhahir. Habeeb. PhD in Industr...
Operational Resources for Hospital Transfusion Services to Initiate Clinical-trial of COVID-19 Conv
Operational Resources for Hospital Transfusion Services to Initiate Clinical-trial of COVID-19 Conv
by ethlyn
Webinar presenters:. Robert Davenport, MD Universi...
Pharmacovigilance in Clinical Trials
Pharmacovigilance in Clinical Trials
by lucinda
Version 04 . Feb. 2021. In . this. . training co...
UC DAVIS OFFICE OF RESEARCH
UC DAVIS OFFICE OF RESEARCH
by olivia-moreira
Overview of Good Clinical Practices (GCP) . Inves...
INVESTOR FACT SHEET
INVESTOR FACT SHEET
by kittie-lecroy
INVESTOR FACT SHEET October 2011 Lipocine Inc. F...
Biosimilars in emerging markets- regulatory and Commercial considerations
Biosimilars in emerging markets- regulatory and Commercial considerations
by jane-oiler
OMIC Group. Biosimilars 2104. Hyderabad. India. 2...
SAFETY PRACTICES AND REPORTING IN CLINICAL RESEARCH
SAFETY PRACTICES AND REPORTING IN CLINICAL RESEARCH
by min-jolicoeur
Acknowledgement. Acknowledgment to . Ms. Chun Ge...